Details for Patent: 10,039,780
✉ Email this page to a colleague
Which drugs does patent 10,039,780 protect, and when does it expire?
Patent 10,039,780 protects KENGREAL and is included in one NDA.
This patent has sixteen patent family members in twelve countries.
Summary for Patent: 10,039,780
Title: | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same |
Abstract: | The present invention relates to high purity cangrelor, pharmaceutical formulations comprising high purity cangrelor as an active ingredient, methods for preparing such compounds and formulations, and methods for using the pharmaceutical formulations in the inhibition of platelet activation and aggregation. |
Inventor(s): | Dutta; Panna (Fleminton, NJ), Rafai Far; Adel (Mount-Royal, CA), Ding; Min (Irvington, NY), Motheram; Rajeshwar (Dayton, NJ) |
Assignee: | Chiesi Farmaceutici S.p.A. (Parma, IT) |
Application Number: | 15/643,745 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,039,780 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 10,039,780
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chiesi | KENGREAL | cangrelor | POWDER;INTRAVENOUS | 204958-001 | Jun 22, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF REDUCING THE RISK OF PERIPROCEDURAL MYOCARDIAL INFARCTION, AND STENT THROMBOSIS IN A PATIENT UNDERGOING PCI BY ADMINISTERING INTRAVENOUSLY 30 UG/KG BOLUS BEFORE PCI AND THEN A CONTINUOUS INFUSION | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,039,780
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | 112017014996 | ⤷ Try a Trial | |||
Canada | 2971868 | ⤷ Try a Trial | |||
Chile | 2017001840 | ⤷ Try a Trial | |||
China | 107206014 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |